These histological findings in a diffuse glioma IDH-wildtype should prompt pathologists to consider FGFR3-TACC3 fusion and look for additional genetic alterations that are required for the diagnosis of GBM, IDHwt. This evidence concerns the gene TACC3 and glioblastoma.